Federated Hermes, Inc. 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 11:22 am Sale | 2023-03-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 0 0.000% | -1,956,488 (Position Closed) | Filing |
| 2023-02-01 09:07 am Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 1,956,488 9.450% | -402,136 (-17.05%) | Filing |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 2,358,624 12.230% | -88,376 (-3.61%) | Filing |
| 2022-02-14 1:31 pm Purchase | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 5,280,847 6.500% | 998,284 (+23.31%) | Filing |
| 2021-02-12 1:16 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 4,282,563 5.400% | 516,198 (+13.71%) | Filing |
| 2021-02-12 1:16 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 2,447,000 12.830% | 1,010,000 (+70.29%) | Filing |
| 2020-11-10 1:32 pm Sale | 2020-10-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 3,766,365 4.750% | -49,935 (-1.31%) | Filing |